Although it has been announced that Mounjaro (Tirzepatide) will become available in primary care settings from Monday, 23 June (for a specific patient cohort) arrangements are being made by Kent and Medway ICB to mobilise a provider of the necessary Behavioural Support for Obesity Prescribing (BSOP) that is specified in the NICE guidelines. Until this…
